Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Cipla Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

12 Apr 2014 Reuters Investment Profile 12 $20.00

Cipla Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

12 Apr 2014 Reuters Investment Profile 12 $20.00

Cipla put call ratio increases 0.7%, stock decreases

Cipla Ltd. (NSE:CIPLA), India's 4th largest pharmaceuticals company by market capitalisation, decreased Rs1.40 (or 0.3%) to c...

15 Apr 2014 News Bites Pty Limited 14 $5.00

Thomson Reuters Stock Report - CIPLA LTD (CIPLA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

15 Apr 2014 Thomson Reuters Stock Report 11 $25.00

Cipla closes at 4.0% above VWP

Cipla Ltd. (NSE:CIPLA), India's 4th largest pharmaceuticals company by market capitalisation, increased Rs4.65 (or 1.2%) to c...

11 Apr 2014 News Bites Pty Limited 14 $5.00

Cipla falls 0.9% in weak trading with bearish open interest

Cipla Ltd. (NSE:CIPLA), India's 4th largest pharmaceuticals company by market capitalisation, decreased Rs3.60 (or 0.9%) to c...

10 Apr 2014 News Bites Pty Limited 14 $5.00

Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review

Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review Summary Cipla Ltd. (Cipla) is a pharmaceutical company. The...

10 Apr 2014 GlobalData 39 $125.00

Cipla in its biggest trailing week gain for 3 months

Cipla Ltd. (NSE:CIPLA), India's 4th largest pharmaceuticals company by market capitalisation, increased Rs4.40 (or 1.1%) to c...

09 Apr 2014 News Bites Pty Limited 14 $5.00

Cipla Limited

Cipla Limited - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the c...

08 Apr 2014 MarketLine (a Datamonitor Company) 38 $175.00

Cipla falls 1.9% in weak trading with bearish open interest

Cipla Ltd. (NSE:CIPLA), India's 4th largest pharmaceuticals company by market capitalisation, decreased Rs7.50 (or 1.9%) to c...

07 Apr 2014 News Bites Pty Limited 14 $5.00